Sarepta Therapeutics, Inc.
$2.27B- Market cap
- $2.38B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · current priceP/S 1.08x
$22.52Latest market snapshot
Implied fair value · at PEP's multiple
$41.6384.9% above market
20.81 SRPT revenue / share×2.00x PEP P/S=$41.63
Market $22.52Implied $41.63
PEP · current priceP/S 2.00x
$137.66Latest market snapshot
Implied fair value · at SRPT's multiple
$74.4645.9% below market
68.81 PEP revenue / share×1.08x SRPT P/S=$74.46
Market $137.66Implied $74.46